Warnex Bioanalytical Services offers a range of services to the pharmaceutical and biotechnology industries, specializing in bioavailability and bioequivalence studies. We support companies in their drug development programs by carrying out analyses generated throughout the program, beginning with pre-clinical studies and proceeding with evaluation of the drug in human clinical trials. Support to the generic drug industry is provided by analyzing physiological fluid samples obtained from clinical studies in humans to determine whether the new formulations are bioequivalent to the marketed product.
A scientific team of specialists in research and development, method development and validation, and production, use state-of-the-art equipment and the latest techniques to develop highly exacting analytical methods that are validated in accordance with the highest standards imposed by both the FDA and the TPD.
Our research and development group is able to develop and validate analytical methods and our production group provides clients with quality services and rapid turnaround time. We have access to an organic synthesis laboratory, which insures that we have the necessary metabolites and internal standards including labelled compounds to conduct even the most demanding studies.
Warnex Bioanalytical Services ensures that our clients receive professional and reliable bioanalytical support with unsurpassed quality levels and delivery schedules. We pride ourselves on our commitment to building strong long-term relationships with our clients, our attention to detail, and our ability to assist our clients in meeting their deadlines.